Podcasts about fda

A review by the U.S. Food and Drug Administration (FDA) identified 51 PFAS in 1,744 cosmetic products. Among the 25 most-used PFAS, 19 lacked sufficient safety data for assessment The most common PFAS in European makeup were polytetrafluoroethylene (PTFE) in 26% of PFAS-positive products and perfluorodecalin in 22%, both used to soften skin In a 2021 study, researchers discovered that 82% of waterproof mascaras and over 60% of tested lipsticks and foundations contained high levels of fluorine, indicating the presence of hidden PFAS Several top brands like Urban Decay, Inglot, L'Oréal, Maybelline, Burt's Bees, and Bare Minerals have faced lawsuits or investigations for PFAS contamination despite being marketed as "natural" or "clean" While the FDA lacks a national ban, U.S. states are now leading the shift toward PFAS-free beauty products — nine states have passed or scheduled bans on intentionally added PFAS in cosmetics through 2032

What if awakening wasn't something you reached for, but something you softened into? In this episode of Why Isn't Everyone Doing This?, Emily sits down with Ma Ananda Sarita, a world-renowned Tantra master, for a quiet, deeply embodied conversation about devotion, presence, and awakening with and as the body. Rather than approaching Tantra as philosophy, technique, or sexuality, Sarita shares it as a lived path of devotion to life itself. A way of being in relationship with breath, sensation, emotion, eros, grief, and the simple truth of what is present. Awakening, she reflects, is not about transcendence or ascent, but about arriving fully into this moment. Together, Emily and Sarita explore what it means to slow down enough to actually feel, to allow life to move you rather than trying to control or optimize your experience, and to trust the body as a source of intelligence and love. They speak about tenderness, surrender, and the feminine way of awakening that unfolds through receptivity, listening, and intimacy with what is real. This episode is an invitation to soften your grip, deepen your presence, and remember that the sacred is not elsewhere. It is already here, waiting to be met. Key Moments 00:00:00 — Opening the space: presence, reverence, and intention00:05:40 — Devotion as lived relationship, not belief or hierarchy00:10:30 — Awakening with and as the body00:16:15 — Slowing down enough to truly feel00:22:45 — Staying present with grief and tenderness00:29:10 — The feminine path of remembering00:35:20 — Allowing life to move you00:41:00 — Trust, surrender, and embodied listening00:47:30 — When practice becomes how you live00:53:10 — Integration and closing reflections For Those Feeling the Call to Go Deeper The themes in this episode — embodiment, nervous system capacity, devotion, and lived integration — are the foundation of Ziva Level 3. Level 3 is for practitioners who feel ready to move beyond peak experiences and into sustained, embodied leadership. Applications close soon: https://zivameditation.com/pages/nextlevel About Sarita Ma Ananda Sarita is a world-renowned Tantra master, author, and teacher with more than five decades of lived experience on the Tantric path. Initiated in the Osho lineage, her work emphasizes awakening through embodiment, intimacy, and devotion to life itself. She teaches Tantra not as technique or performance, but as a path of surrender and presence, where the body becomes a doorway to truth, love, and realization. Learn more: https://www.anandasarita.com/ Instagram: https://www.instagram.com/sarita.love More from Emily & Ziva https://zivameditation.com/pages/zivamagic https://upgradedformulas.com/emily and use code EMILY for 20% off everything at https://upgradedformulas.com These statements have not been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider if pregnant or nursing, taking medication, or if you have a medical condition.

There has been a shift in cervical cancer screening from primary cytology based to HPV based. Even HPV screening has had its evolution from physician collected samples to patient self-collection, either in a clinical setting or at home with an approved collection system. In May 2025, the FDA cleared the first at-home self-collection kit for HPV screening, specifically the Teal Wand by Teal Health. Now, we are seeing the advent of POSSIBLY another avenue for cervical HPV testing- although it is a bit awkward: the use of menstrual blood as an HPV screening test. In this episode we will review a new cross-sectional, population-based study from China which compared testing menstrual blood for human papillomavirus during cervical cancer screening to clinician-collected cervical samples for human papillomavirus (HPV). This concept, and these results, are not new at all! And there are important limitations to consider at this time. Listen in for details.1. Testing menstrual blood for human papillomavirus during cervical cancer screening in China: cross sectional population based study. BMJ 2026; 392 doi: https://doi.org/10.1136/bmj-2025-084831 (Published 04 February 2026)BMJ 2026;392:e084831https://www.bmj.com/content/392/bmj-2025-0848312. Naseri S, Young S, Cruz G, Blumenthal PD. Screening for High-Risk Human Papillomavirus Using Passive, Self-Collected Menstrual Blood. Obstet Gynecol. 2022 Sep 1;140(3):470-476. doi: 10.1097/AOG.0000000000004904. Epub 2022 Aug 3. PMID: 35926207; PMCID: PMC9377370.3. Fokom Domgue J, Chandra M, Oladoyin O, Desai M, Yu R, Shete S. Women's Preferences for Home-Based Self-Sampling or Clinic-Based Testing for Cervical Cancer Screening. JAMA Netw Open. 2026;9(2):e2558841. doi:10.1001/jamanetworkopen.2025.58841

It's In the News.. a look at the top headlines and stories in the diabetes community. This week's top stories: T1D in the Olympics & Superbowl, Trump RX goes live, Ozempic pill available soon, tech updates from Medtronic, Beta Bionics, Eversense 365 and more! Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  T1D Screening info All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Episode transcription with links: Welcome! I'm your host Stacey Simms and this is an In The News episode.. where we bringing you the top diabetes stories and headlines happening now. A reminder that you can find the sources and links and a transcript and more info for every story mentioned here in the show notes. Quick reminder: We are just over one week from our first Moms' Night Out event of the year. While the plans are all set – the speakers, the vendors, the raffles and the fun is ready to go, it's always amazing how many people hear of these event last minute. That's fine, they're welcome! But if you're thinking of attending a future event – registration is open for We're going to Nashville next March 6-7 and Detroit in September – no need to wait. And we've got Club 1921 events for health care professionals and patient leaders in 6 cities this year! All the info is over at diabetes-connetionss.com events/   Okay.. our top story this week: XX Gotta be a quick shout out to some incredible T1D athletes – we had TWO in the super bowl this past weekend – Chad Muma of the New England Patriots and Logan Brown of the Seattle Seahawks AND there are at least two athletes with type 1 competing at the Winter Olympics. Hannah Schmidt competes in ski cross for Canada – she was diagnosed with Type 1 diabetes at age 12 years old.  Anna FarnSchadt Fernstäd a Czech skeleton racer diagnosed in 2022 after she'd already been to several Olympics. We wish them all the best!   https://english.radio.cz/skeleton-racer-anna-fernstadtova-overcoming-adversity-headfirst-down-ice-8876699 XX The government website TrumpRx.gov is live..  the website does not sell prescription drugs. Instead, it allows people to look up their drugs and then navigate to buy them elsewhere, either from a major drug company or a pharmacy. The 43 drugs listed on the site have prices ranging from $3 to over $5,500. TrumpRx does include warnings that the site may not be the best option to save money on prescriptions. Each product page advises: "If you have insurance, check your co-pay first — it may be even lower." For now, the website says its prices are for people paying with their own money, rather than going through insurance. The only insulin listed right now is Lilly's insulin lispro – and it's the same price as you'd find through Illy's insulin value program. I looked up diabetes meds.. For example, if you have an insurance co-pay of $25 a month for Farxiga, a drug often used for diabetes, you would be paying $182 on TrumpRx. As you can imagine, though ,this is complicated and as with most of our healthcare system, it may be good in some cases and not much help in other.  I'd suggest calling your local pharmacist or checking with your human resource dept. https://www.nytimes.com/2026/02/06/health/trumprx-prescription-drug-prices-consumers.html XX Novo Nordisk will launch some doses of its oral semaglutide for diabetes under the brand name Ozempic pill in the second quarter of this year. The company said the U.S. Food and Drug Administration has approved Ozempic tablets in three different doses. Novo says The new Ozempic name is intended to help patients and health care professionals more easily recognize the available treatment options for type 2 diabetes Semaglutide tablets have been available under the brand name Rybelsus Ruh BELL sis for diabetes since 2019 but with different dosing. The pill is also approved to reduce the risk of certain cardiovascular conditions in adults with type 2 diabetes who are at high risk for these events. The FDA had approved the new doses based on a bioequivalence study and the clinical trial data for Rybelsus, Novo said. https://www.reuters.com/business/healthcare-pharmaceuticals/novo-launch-ozempic-pill-diabetes-second-quarter-this-year-2026-02-04/ XX https://www.contemporarypediatrics.com/view/early-screening-for-type-1-diabetes-found-effective-in-children XX Possible new way to identify and track the progress of type 1 diabetes before clinical onset. A recent study published in Science Advances described the application of subcutaneous microporous scaffolds. These are inserted and have been shown to  identify changes in cancer, multiple sclerosis, and T1D by capturing changes of immune cells over the course of a disease. This is a proof of concept study in mice.. so very early days. https://www.news-medical.net/news/20260204/Implantable-immune-scaffold-predicts-type-1-diabetes-weeks-before-symptoms.aspx XX A large global genetics study shows that many key drivers of Type 2 diabetes operate outside the bloodstream. In a major international project led in part by the University of Massachusetts Amherst and Helmholtz Munich in Germany, researchers linked hundreds of genes and proteins to the disease. The work, published in Nature Metabolism, points to a key challenge in diabetes research: the biology behind rising blood sugar does not play out the same way in every part of the body. It also shows why including people from many backgrounds matters, since genetic clues that stand out in one population may be faint or invisible in another. Huge study, 2.5 million people worldwide comparing patterns across seven tissues tied to diabetes and four global ancestry groups, then asked a simple question: what do you miss if you only measure blood? Across the seven tissues, the researchers found causal evidence pointing to 676 genes. Yet overlap with blood was limited: only 18% of genes with a causal effect in a primary diabetes tissue, such as the pancreas, showed a matching signal in blood. At the same time, 85% of genetic effects observed in diabetes-relevant tissues were completely absent from blood-based analyses. The findings lay out a roadmap for future research aimed at understanding the biological pathways underlying Type 2 diabetes and developing more effective treatments. https://scitechdaily.com/massive-global-study-rewrites-the-biology-of-type-2-diabetes/ XX Express Scripts settled the U.S. Federal Trade Commission's claims its insulin pricing practices violated antitrust and consumer protection laws, and agreed to changes aimed at lowering costs for patients, insurers and small pharmacies The settlement, first reported by Reuters, fits with that goal, and allows the FTC to pare down a case brought by the former Biden administration against Cigna's Express Scripts, UnitedHealth Group Inc's (UNH.N), Optum unit and CVS Health Corp's (CVS.N), CVS Caremark. The case against Optum and Caremark is ongoing. Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced a decade of scrutiny from regulators and lawmakers over pricing practices. While the industry has already made reforms, the settlement gives the FTC power to enforce broader changes at Express Scripts. The 10-year agreement restricts Express Scripts' ability to engage in practices critics say contribute to high costs, like pocketing rebate payments from drugmakers based on the list price of drugs. The FTC estimates the agreement could save patients as much as $7 billion over a decade. https://www.reuters.com/world/cigna-settles-ftc-insulin-case-commits-overhauling-drug-pricing-2026-02-04/ XX Audio? Congress has passed bipartisan legislation to extend and strengthen the Special Diabetes Program (SDP), a cornerstone of Federal investment in type 1 diabetes (T1D) research. The President signed the legislation and it is now law. Extends the SDP through December 31, 2026, and increases funding from $160 million to $200 million annually. Strengthens overall funding for the National Institutes of Health (NIH) by $415 million. Increases diabetes research funding at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) by $10 million. Created by Congress and administered by the NIH, the SDP has contributed nearly $3.6 billion to T1D research and has played a role in nearly every major breakthrough in the field. A recent study conducted by Avalere Health shows that of the nearly 3.6 billion invested into the SDP by Congress since the establishment of the program, the Federal Government has realized $50 billion in healthcare savings through improved health outcomes from the use of SDP driven therapies and devices https://www.breakthrought1d.org/news-and-updates/congress-passes-bipartisan-extension-of-the-special-diabetes-program-securing-critical-t1d-research-funding/ XX Dexcom is rolling out what they're calling AI-enabled enhancements to Stelo, further transforming how users track and understand their glucose health. Expanded Smart Food Logging including a comprehensive nutrition database of more than 1M meals that provides a breakdown of calories, carbohydrates, protein, fat, dietary fibers, and more. More ways to meal track including text search, barcode scanning or taking a photo of the meal, creating a seamless and intuitive meal tracking solution. A redesigned Daily Insights feature which will introduce a new interface with more personalized recommendations. The newest features will launch nationwide in the coming weeks.  XX Beta Bionics has received a warning letter from the Food and Drug Administration following an inspection last year, the company disclosed on Friday. The diabetes technology company said in a securities filing that the warning letter concerns non-conformities with the company's quality management system, medical device reporting, and correction and removals. The warning letter has not yet been posted by the FDA.   The company said in the filing that it has already taken actions to improve the processes described in the warning letter, and it is working on a written response to the FDA.   The firm does not expect the warning letter to affect the planned launch of a new insulin patch pump by the end of 2027. Beta Bionics unveiled a prototype of the device, called Mint, last year at the American Diabetes Association's Scientific Sessions. The company also does not expect the warning letter to affect its financial results. https://www.medtechdive.com/news/beta-bionics-receives-fda-warning-letter/811140/?utm_source=Sailthru&utm_medium=email&utm_campaign=Issue%3A+2026-02-04+MedTech+Dive+%5Bissue%3A81423%5D&utm_term=MedTech+Dive&fbclid=IwY2xjawPwhDZleHRuA2FlbQIxMABicmlkETFaUUcyYmNQWldjZ2xudElic3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MgABHouF8M3IstTyslPRgeHWUWVVdOAGOtzPWt_yNFcj9eYruqSPz3e86Iwcbpt8_aem_7q4D97vJVjHKfEwvoyUpgw XX Sequel Med Tech is reviewing co-founder Dean Kamen's ties to Jeffrey Epstein after recently released documents revealed new details about the longstanding relationship between the two men. The documents show that Kamen visited Epstein's island, and remained in contact with him for years after Epstein was convicted of sex crimes involving minors. Kamen has not been accused of any wrongdoing. In a statement, Sequel Med Tech said the Manchester-based company is aware of the documents pertaining to Kamen and – quote - "Sequel's Board of Directors has unanimously decided to engage an external law firm to review these disclosures and provide recommendations aligned with our mission to serve people living with diabetes," Kamen has not issued a statement regarding his reported connection to Epstein.   https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.bostonglobe.com/2026/02/04/metro/nh-dean-kamen-jeffrey-epstein-review/ https://www.nbcboston.com/news/local/nh-inventor-placed-on-leave-after-epstein-messages-surface-report-says/3888569/ XX Abbot reports 860 serious injuries linked to the recall of some of its glucose monitoring sensors. We told you about this recall late last year, these numbers are an FDA update.     Abbott said the sensors can provide incorrect glucose readings over extended periods, which could lead to users making dangerous treatment decisions, including eating excessive carbohydrates along with skipping or delaying insulin doses, potentially leading to serious health risks. The company said it has identified and resolved the cause of the issue, which relates to one production line among several that make Libre 3 and Libre 3 Plus sensors.   https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-recalls-glucose-sensors-after-seven-deaths-linked-faulty-readings-2026-02-04/ XX Updates from Medtronic & Senseonics – and a first from Nick Jonas.. right after this..   I'm excited to share that the FDA has cleared the MiniMed 780G system with the Instinct sensor, made by Abbott, for people with type 2 diabetes.  Medicare has also now approved coverage for the Instinct sensor for use with the MiniMed 780G system. This clearance and expanded coverage mean more people will have access to pairing our most advanced automated insulin delivery technology with the Instinct sensor, that offers a smaller, 15-day sensor experience.  They're also launching the MiniMed 780G system Pump Evaluation Program.  This program gives individuals living with diabetes the ability to try the full MiniMed 780G system at no cost for 30 days.† This includes the pump, the sensor of their choice, one month of infusion sets and reservoirs, everything but the insulin. They'll contact your doctor for you to get a prescription and get the process rolling. https://www.medtronicdiabetes.com/pump-evaluation-program XX Senseonics announced today that its Eversense 365 continuous glucose monitor (CGM) system received CE mark approval – that's European clearance.  This comes on the heels of the launch of Eversense 365 with Sequel Med Tech's twiist pump, marking the first pump integration for the CGM. Senseonics plans to launch Eversense 365 in Germany, Italy, Spain and Sweden in the coming months. Meanwhile, Senseonics continues to work toward an FDA investigational device exemption (IDE) submission for its next-generation Gemini transmitter-less CGM by the end of this year. https://www.drugdeliverybusiness.com/senseonics-ce-mark-eversense-365-cgm/ XX A huge shout out to Dr. Emily Blum, who just accomplished riding 100 miles in Antarctica for Breakthrough T1D! Despite having no direct connection to Type 1 Diabetes, Emily has been riding and fundraising for BreakthroughT1D for 10 years now. She is an integral part of the Georgia Ride team, training and riding many miles, and most importantly has raised tens of thousands of dollars to support the cause of ridding the world of T1D. She is surgeon and deeply involved with medical innovation, with an incredibly busy schedule, but jumped at the chance to take on the challenge of riding a century on every continent. Having already completed North America, Europe, Australia, Asia, and now Antarctica, only Africa and South America remain. Emily rides on and continues to be an inspiration to everyone who meets her. XX   https://diabetes-connections.com/t1d-connection-and-people-magazine-elise-zach-share-their-story/ XX Nick Jonas's becomes the first artist ever to wear a CGM on an album cover - new upcoming solo album Sunday Best, releasing Feb. 6.  The release says: This marks a powerful step forward in normalizing diabetes and raising awareness for the condition on a global scale. This moment adds to the growing visibility of diabetes in pop culture, alongside milestones like a Type 1 diabetes Barbie and Pixar characters wearing diabetes technology.

February 10, 2026: Your daily rundown of health and wellness news, in under 5 minutes. Today's top stories: Apple scraps AI-powered health coach project after delays, concluding it wasn't keeping pace with competitors like Oura, Whoop, and Ultrahuman Oura files patent for AR smart glasses displaying real-time health data controlled through ring-based gestures, positioning itself at center of ambient health tracking Hims & Hers pulls compounded oral GLP-1 pill amid regulatory pressure from HHS and FDA, with Novo Nordisk suing for patent infringement More from Fitt: Fitt Insider breaks down the convergence of fitness, wellness, and healthcare — and what it means for business, culture, and capital. Subscribe to our newsletter → insider.fitt.co/subscribe Work with our recruiting firm → https://talent.fitt.co/ Follow us on Instagram → https://www.instagram.com/fittinsider/ Follow us on LinkedIn → linkedin.com/company/fittinsider Reach out → insider@fitt.co  

Is the food you feed your children safe? Florida first lady Casey DeSantis joins me to reveal the shocking truth about toxins in America's food supply. Casey DeSantis discusses her groundbreaking new initiative, ExposingToxicFoods.com. While the FDA and EPA have been asleep at the wheel, Florida has taken matters into its own hands — testing common grocery store items like baby formula, candy, and bread. The results are terrifying. From arsenic and lead to glyphosate and heavy metals, the "safe" foods we have trusted for decades are fueling a chronic illness epidemic. We cover how Florida is leading the charge on informed consent and to get to the bottom of the chronic illness epidemic. This is just the beginning of the first lady's fight for food safety and informed consent.  Learn more about your ad choices. Visit megaphone.fm/adchoices

In this podcast, Kyle welcomes Aaron Siri, a prominent legal advocate known for his work with the Informed Consent Action Network (ICAN) and Del Bigtree's Highwire, who has been influential in uncovering pharmaceutical industry practices. The conversation revolves around Siri's new book, 'Vaccines. Amen,' which critiques the almost religious zeal with which vaccines are regarded and delves into various controversial aspects of vaccine safety and policy. Siri discusses the deficiencies in safety testing of vaccines, such as the Hepatitis B vaccine trials involving infants, and highlights how the 1986 National Childhood Vaccine Injury Act shifted the responsibility of vaccine safety from manufacturers to the federal government, resulting in a lack of accountability. The conversation also explores the history and efficacy of the Measles vaccine, potential long-term health impacts of vaccines, and the broader implications of governmental and pharmaceutical industry practices. Kyle and Siri emphasize the importance of individual choice and informed consent in vaccination decisions, criticizing the lack of transparency and the ethical implications of government-mandated vaccines. The discussion concludes with reflections on the future of vaccine policy and the importance of maintaining personal freedoms and rights. Aaron Siri is the managing partner of Siri and Glimstad, where he focuses on civil rights, informed consent, class actions, and complex civil litigation. His work includes challenging medical mandates, defending parental rights, representing whistleblowers, and forcing government transparency, including litigation that compelled the FDA to release Pfizer COVID 19 records. Aaron previously practiced at Latham and Watkins and clerked for the Chief Justice of the Supreme Court of Israel. He earned his law degree from UC Berkeley School of Law, where he served as Editor in Chief of the Berkeley Business Law Journal.   From Kyle: The Community is coming! Click here to learn more   Connect with Aaron here: Instagram Website Siri & Glimstad LLP   Our Sponsors: Let's level up your nicotine routine with Lucy. Go to Lucy.co/KKP and use promo code (KKP) to get 20% off your first order. Lucy offers FREE SHIPPING and has a 30-day refund policy if you change your mind.   Connect with Kyle: I'm back on Instagram, come say hey @kylekingsbu Twitter: @kingsbu Our Farm Initiative: @gardenersofeden.earth Odysee: odysee.com/@KyleKingsburypod Youtube: https://www.youtube.com/@Kyle-Kingsbury Kyle's Website: www.kingsbu.com - Gardeners of Eden site If you enjoyed this podcast, please subscribe & leave a 5-star review with your thoughts!

In this episode of Finding Freedom, host John Odermatt examines the rise of GLP-1 drugs like Ozempic and Wegovy, exploring how they work by overriding the body's natural hunger signaling through synthetic peptides inspired by Gila monster venom. While acknowledging these medications have legitimate applications for severe obesity and diabetes, John raises concerns about FDA-listed side effects including muscle loss, stomach paralysis, and thyroid tumor warnings, especially as Trump's new RX.gov platform makes these drugs more affordable and accessible. Drawing from his personal experience losing 50 pounds and maintaining the weight loss, John argues that synthetic GLP-1s don't address root metabolic dysfunction caused by poor diet, sedentary lifestyle, and chronic inflammation. He advocates for natural alternatives like berberine, chromium polynicotinate, and polydextrose fiber that support the body's own GLP-1 production rather than overriding it. John emphasizes the importance of building sustainable habits through diet, exercise, and supplementation that restore metabolic function instead of creating pharmaceutical dependency. The episode concludes with a call to prioritize long-term health over quick fixes, warning that rapid weight loss without muscle maintenance could lead to premature aging and sarcopenia. CHAPTERS: 0:00 - Introduction: GLP-1 Drugs Overview0:54 - Welcome & Episode Preview1:16 - Sponsor: Fox and Sons Coffee2:18 - John's Personal Weight Loss Journey4:49 - Trump RX.gov Announcement & Concerns10:22 - What is GLP-1? Understanding the Science13:46 - FDA-Listed Side Effects & Risks17:12 - Root Causes of Metabolic Dysfunction20:22 - Natural Alternative #1: Berberine22:32 - Natural Alternative #2: Chromium Polynicotinate23:34 - Natural Alternative #3: Polydextrose Fiber27:15 - Lifestyle Balance & Sustainable Habits30:29 - The Danger of Quick Fixes31:47 - Natural Supplements Recap & Resources34:45 - Final Thoughts & Call to Action36:33 - Support Lions of Liberty LINKS: John Odermatt on Twitter: @JohnOdermattJohn Odermatt on Instagram: @JohnOdermattEmail: John@LionsofLiberty.comNewsletter: https://john-odermatt-finding-freedom.kit.com/105b53c794Trump RX.gov: https://trumprx.gov SPONSOR: This episode is brought to you by Fox and Sons Coffee – fresh, high-quality coffee shipped directly to your door, available as whole bean or ground to your preference. Get 15% off orders of $40 or more with promo code JOHN at checkout.Visit: FoxNSons.com SUPPORT LIONS OF LIBERTY: Help keep this podcast going! We rely on listener support to continue bringing you content on health, freedom, and personal empowerment.Support us on Patreon: https://patreon.com/lionsoflibertySupport us on Locals: https://lionsofliberty.locals.com/Subscribe, rate, and review wherever you listen – it makes a huge difference! Learn more about your ad choices. Visit megaphone.fm/adchoices

Plus: Shares in Novo Nordisk rally after the FDA clamps down on companies making compound versions of weight-loss drug Wegovy. And SpaceX delays a planned Mars mission to focus on Nasa's next moon landing. Daniel Bach hosts. Sign up for WSJ's free What's News newsletter. Learn more about your ad choices. Visit megaphone.fm/adchoices

National Economic Council Director Kevin Hassett discusses America's economic trajectory, including the jobs market and productivity, inflation, and President Trump's pick for new Fed chair, Kevin Warsh. Direct-to-consumer telehealth Hims & Hers made waves last month when it announced a cheaper, compounded obesity pill similar to Wegovy. Now, after the FDA warned against compounded GLP-1s, Hims & Hers is backing off. Former FDA Commissioner Dr. Scott Gottlieb discusses competition in obesity drugs, Novo Nordisk's lawsuit against Hims & Hers, and the importance of vaccines. Plus, the pharma and AI ads at Super Bowl LX, Japanese Prime Minister Sanae Takaichi secured a supermajority in a snap election, and CNBC's Emily Wilkins reports on the legislative efforts to address the U.S. housing affordability crisis. Emily Wilkins - 10:09Kevin Hassett - 19:21Dr. Scott Gottlieb - 30:10In this episode:Emily Wilkins, @emrwilkinsBecky Quick, @BeckyQuickJoe Kernen, @JoeSquawkAndrew Ross Sorkin, @andrewrsorkinCameron Costa, @CameronCostaNY Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, we're speaking with Cindy Perettie, Executive Vice President and Global Head at Kite Pharma, a Gilead-owned company focused on curing cancer with cell therapies. Perettie talks about scaling cell therapies in the community setting, global manufacturing strategy, preparing for the launch of late-stage development programs in lymphoma and multiple myeloma, and working with partners like Arcellx. She also discusses cell therapy funding cycles and big pharma, the autologous versus allogeneic divide, why in vivo CAR-T therapies could be a game changer, what the FDA's focus on cell and gene therapies could mean for U.S. competition, and more. Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

If you're considering freezing your eggs: This one's for you. Fashion influencer and writer Lily Montasser built her platform sharing effortlessly cool style, NYC life, and sharp, honest storytelling. But recently, she opened up about something far more personal: her decision to freeze her eggs. Instead of keeping it private, Lily brought her followers along for the ride — partnering with Extend Fertility for her treatment, documenting the appointments, the hormones, the doubts, and the unexpected empowerment of taking control of her fertility timeline. In this episode, Ali and Lily talk about what it really feels like to make proactive choices about your future, how Lily felt sexier than ever going through the process, how sharing vulnerably online changed the experience, and why more women are rethinking the “someday” conversation around family-building.Follow her on IG: @lilymontasserSubstack: lilymontasser.substack.comCheck out Extend Fertility: www.extendfertility.com EPISODE SPONSORS: WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.Order "Work of ART," "Beautiful Bird" and "You Are a Work of ART," now at https://www.infertileafgroup.com/booksFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipPHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.BERRY FERTILITYIG: @berry.fertilityThe Berry Fertility app is packed with support: dozens of injection tutorials, over 100 articles, 200 FAQs, and if you still have questions, the Berry team is literally a tap away through in-app chat.Berry has a free version, and you can try Premium free for seven days. After that, it's $12.99 a month or $99 for the year.InfertileAF listeners get 30% off an annual membership with the code INFERTILEAF when you sign up at berryfertility.com or in the Berry Fertility app.Our Sponsors:* Check out BetterHelp: https://www.betterhelp.comSupport this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

On this episode of Vitality Radio, Jared sits down with returning guest Jamie Cotter, national educator for WishGarden Herbs, to break down immunity in a way that actually makes sense. Instead of treating the immune system as a one-size-fits-all problem, Jamie explains the four distinct phases of immunity—daily immune maintenance, early onset, active illness, and recovery—and why each phase benefits from a different herbal strategy. You'll learn how tonic herbs support baseline immune resilience, why timing and dosing matter when symptoms first appear, and how targeted herbal formulas can support the body during active immune challenges and lingering recovery phases. This episode empowers listeners to better understand their own immune responses and make informed choices about herbal support, seasonal wellness routines, and immune preparedness—without fear, hype, or guesswork.Products Discussed:Daily ImmuneKick-Ass ImmuneSerious V-FighterDeep LungKick-Ass BioticGet Over It!Buy 4 or more Wishgarden products from HERE and get 25% off through March 7, 2026!Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this Editor's Special Episode of The HemOncPulse, a conversation with Nicholas Richardson, DO, MPH, vice president of clinical development at Precision for Medicine, focuses on the evolving regulatory role of measurable residual disease in multiple myeloma clinical trials. The discussion is designed to contextualize recent FDA draft guidance for a broad clinical and research audience.

This episode covers: • Longevity Influence In The Epstein Files A new DOJ document release tied to the Epstein investigation pulled physician and longevity influencer Peter Attia into the spotlight, after reports showed he appeared in the files more than 1,800 times and CBS News pulled a planned rebroadcast of its 60 Minutes profile. Dave breaks down why this story matters beyond headlines: longevity relies heavily on trust, authority, and influence, and when those foundations are shaken it exposes how fragile centralized expertise can be. He explains how biohackers can protect themselves by diversifying information sources, understanding mechanisms instead of personalities, and building health strategies that don't collapse when one voice disappears. • Source: https://variety.com/2026/tv/news/cbs-news-pulls-peter-attia-60-minutes-segment-epstein-1236650930/ • Age-Reversal Gene Therapy Enters Human Trials Life Biosciences received FDA authorization to begin the first U.S. human trial of a partial epigenetic reprogramming gene therapy in the eye, using three Yamanaka factors to restore function in damaged retinal cells. Dave explains why eyes are the ideal first testing ground, what partial reprogramming actually means, and why this marks a shift from longevity theory into real clinical testing. He also clarifies what success would and would not mean for whole-body rejuvenation, and how to separate legitimate gene-therapy advances from consumer products that only claim to affect biological age. • Source: https://fortune.com/2026/01/30/billionaires-longevity-aging-fda-human-clinical-trial-life-biosciences/ • Continuous Ketone Monitoring Moves Toward Reality Wearable continuous ketone monitoring is advancing beyond finger-stick meters, with companies adapting the same model that made continuous glucose monitors mainstream. Dave explains why this is a major upgrade for metabolic flexibility, keto diets, fasting, and diabetes risk management. He breaks down how real-time ketone data can reveal patterns missed by spot checks, and why biohackers should think ahead about data ownership, integration, and how ketone signals interact with glucose, sleep, stress, and training. • Source: https://finance.yahoo.com/news/global-market-blood-ketone-meters-140900796.html • Injectable, Wireless Brain Implants Without Surgery Researchers are developing nano-scale, wireless brain implants capable of crossing the blood-brain barrier without open surgery, opening the door to a new class of neural interfaces. Dave connects this research to other circuit-level interventions like sound and light stimulation, explaining the broader shift from targeting molecules to tuning brain networks. He also addresses the ethical risks, including consent, privacy, and neuro-surveillance, and why biohackers should track this space early rather than after it becomes normalized. • Source: https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/ • Generic GLP-1 Drugs Could Reshape Global Metabolic Health India's Sun Pharma is preparing to launch a generic semaglutide-style injectable as patent protections expire, signaling a major price drop and access expansion for GLP-1 drugs. Dave explains why this could transform obesity, diabetes, and cardiovascular disease management worldwide, while also highlighting the risks of muscle loss and metabolic weakness if these drugs are used without proper training and nutrition. He shares how biohackers should think about stacking GLP-1s intelligently, with resistance training, protein intake, and long-term maintenance strategies. • Source: https://longevity.technology/unlocked/longevity-news-roundup-week-5-2026/ All source links are provided for direct access to the original reporting and research. This episode is designed for biohackers, longevity seekers, and high-performance listeners who want clear thinking in a noisy health landscape. Host Dave Asprey connects ethics, emerging science, metabolic data, neurotechnology, and drug access into practical lessons for building a resilient, adaptable health strategy that works even as trends and narratives change. New episodes every Tuesday, Thursday, Friday, and Sunday. Keywords: longevity influencer ethics, Peter Attia Epstein files, trust in longevity science, epigenetic reprogramming gene therapy, Yamanaka factors OSK, age reversal human trials, Life Biosciences FDA trial, continuous ketone monitoring, CKM metabolic tracking, glucose ketone wearable sensors, Abbott Libre ketone sensor, metabolic flexibility biohacking, wireless brain implants, blood brain barrier neurotech, cognitive longevity technology, GLP-1 generic semaglutide, Sun Pharma GLP-1, GLP-1 muscle loss prevention, resistance training longevity, metabolic health upgrades, biohacking Thank you to our sponsors! - GOT MOLD? | Go to http://gotmold.com/shop and use DAVE10 to save 10% and see what's in your air.- Essentia | Go to https://myessentia.com/dave and use code DAVE for $100 off The Dave Asprey Upgrade.Resources: • Subscribe to my weekly newsletter: https://substack.daveasprey.com/welcome • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com • 40 Years of Zen: https://40yearsofzen.com Timestamps: 0:00 - Intro 0:18 - Story 1: Attia Epstein Controversy 1:34 - Story 2: Life Biosciences Gene Therapy Trial 2:44 - Story 3: Continuous Ketone Monitoring 3:50 - Story 4: Wireless Brain Implants 4:53 - Story 5: Generic GLP-1 Drugs 6:00 - Closing Thoughts See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

"You also want to deal with patient preferences. We do want to get their disease under control. We want to make them live a long, good quality of life. But do they want to come to the clinic once a week? Is it a far distance? Is geography a problem? Do they prefer not taking oral chemotherapies at home? We have to think about what the patient's preferences are to some degree and kind of incorporate that in our decision-making plan for treatments for relapsed and refractory myeloma," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about multiple myeloma treatment considerations. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by February 6, 2027. Ann McNeill has disclosed a speakers bureau relationship with Pfizer. This financial relationship has been mitigated. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to the treatment of multiple myeloma. Episode Notes  Complete this evaluation for free NCPD. ONS Podcast™ episodes: Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 395: Pharmacology 101: Monoclonal Antibodies Episode 372: Pharmacology 101: Proteasome Inhibitors ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments New Multiple Myeloma Treatments Present New Challenges in Side Effect Management Reduce Racial Barriers and Care Inequities for Black and African American Patients With Multiple Myeloma ONS Voice FDA approval alerts ONS Voice oncology drug reference sheets: Belantamab mafodotin-blmf Daratumumab Motixafortide Selinexor Clinical Journal of Oncology Nursing articles: Journey of a Patient With Multiple Myeloma Undergoing Autologous Stem Cell Transplantation Optimizing Transitions of Care in Multiple Myeloma Immunotherapy: Nurse Roles Oncology Nursing Forum article: Facilitators of Multiple Myeloma Treatment: A Qualitative Study ONS books: Hematopoietic Stem Cell Transplantation: A Manual for Nursing Practice (third edition) Multiple Myeloma: A Textbook for Nurses (third edition) ONS course: ONS Hematopoietic Stem Cell Transplantation™ ONS Huddle Cards: Financial Toxicity Hematopoietic Stem Cell Transplantation (HSCT) Monoclonal Antibodies ONS Hematology, Cellular Therapy, and Stem Cell Transplantation Learning Library American Society of Clinical Oncology (ASCO)–Ontario Health: Treatment of Multiple Myeloma Living Guideline International Myeloma Foundation: Clinical Trials Fact Sheets Clinical Trial Support Resource Library Multiple Myeloma Research Foundation resource: Treatments for Multiple Myeloma To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "Typically for our first-line therapies, we use certain classes of drugs and some of them are proteasome inhibitors like bortezomib and carfilzomib. We also have IMiDs or immunomodulatory agents like thalidomide, lenalidomide, and pomalidomide. We have monoclonal antibodies, anti-CD38 monoclonal antibodies. Of course, we can never talk about treatment for myeloma without mentioning dexamethasone. It is an integral part of our treatment regimen. Most of our frontline therapies now are not just a single agent. They're not even doublets anymore. Typically, they're triplet therapies. And now in 2026, it's leaning more toward quadruplet therapies. By that, I mean you're taking a proteasome inhibitor, an immunomodulatory drug, dexamethasone, and an anti-CD38 monoclonal antibody all together to present patients with a good chance their induction therapy will lead to a good chance of them responding to treatment." TS 4:25 "[With] myeloma labs, there should be some indication after each cycle of therapy that the treatment is working. So, you don't have to do a whole myeloma panel, but maybe getting a monoclonal protein spike, maybe getting a free light chain assay, or maybe an immunoglobulin G or immunoglobulin A level, just to see if the treatment is working. So, those labs are crucial to determine whether the therapies are working. And again, the lab improvements usually correlate with the clinical presentation of the patient." TS 11:01 "There are active clinical trials ongoing with drugs like cell mods. Cell mods are the new oral anticancer agents for myeloma that have shown great promise with efficacy and safety profiles. And then there are other combinations that are showing a lot of promise. So, drugs that are already approved by the U.S. Food and Drug Administration (FDA). And I'm talking about pairing anti-CD38 monoclonal antibodies with bispecific T-cell engagers. If you do that, there has been some evidence that these combinations are very efficacious and responses are durable. And there are ongoing clinical trials and studies being done right now to see if these can be FDA-approved to pinpoint where they are as far as in comparison to other treatments." TS 20:10 "I always tell patients to try to participate in safe, and I want to stress safe, physical activity. So, I tell patients, the more you sit on the couch or you sit in the chair for most of the day, that unfortunately will make your pain worse. So, trying to get up and about and doing some physical activity, such as getting a physical therapy evaluation and a treatment program, no matter how passive or mild or gentle it is, can really help these patients with bone pain." TS 26:10 "I think it's important to realize that myeloma has had amazing advances in science, research and treatments. I think that all of these things coming together, all the science and clinical trials and everything like that, has led to a significant increase in overall survival of our patients, which ultimately is a great thing. We want patients to live longer and they're living longer with a very good quality of life. So, I think it's important to realize that myeloma is very well studied, very well researched, and it's still ongoing with many, many clinical trials." TS 36:04

Send us a textBob Hankins brings over 20 years of dedicated experience in the medical-device industry, spanning engineering leadership, product development, process improvement and strategic technical oversight. As Director of Engineering at TE Connectivity, he leads a global team of engineers and scientists focused on designing, developing and delivering innovative customer-centric medical device solutions—particularly complex machined, extruded and laser-cut components. In this role he ensures design for manufacturing and quality within ISO 13485-compliant systems, marrying deep technical understanding with regulatory-driven manufacturing discipline.Before his current role Bob led Research & Product Development Engineering at Nordson Medical and has held key leadership positions at several medical-device companies, including overseeing product development platforms, multi-site engineering operations, manufacturing automation and system launches. Throughout his career he has honed core competencies in manufacturing process improvement, continuous improvement (including Six Sigma/Lean methodologies), design for manufacturing/assembly, regulatory compliance (ISO 13485, ISO 14971, FDA), and product R&D for the health-care market.Bob's academic background includes a Bachelor of Science in Mechanical Engineering from the University of California, Irvine, and an Executive MBA from the Drucker School at Claremont Graduate University. This combination of technical and business education supports his ability to lead engineering organizations in bridging innovation with operational execution, customer development and quality.In this episode we'll dive into how Bob thinks about leading engineering teams in the regulated medical-device space, how he drives design and process improvements globally, how he balances innovation with manufacturing rigor, and what advice he has for engineers growing into leadership roles in healthcare technology. We'll also explore his views on what the next wave of medical-device manufacturing and design looks like—and how engineering leaders can foster a culture of excellence, empowerment and impact. LINKS:Guest LinkedIn: https://www.linkedin.com/in/rthankins/Guest website: https://www.te.com/en/home.html Aaron Moncur, hostThe Wave is  a place for engineers to actively learn, share ideas, and engage with people doing similar work. Learn more at thewave.engineer Subscribe to the show to get notified so you don't miss new episodes every Friday.The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us Watch the show on YouTube: www.youtube.com/@TeamPipelineus

Sex Care is Self Care host Patty Brisben sits down with urologist, menopause expert, and bestselling author Dr. Kelly Casperson to talk about her powerful new book, The Menopause Moment. Together, they unpack why menopause is not a medical footnote, but a pivotal moment in women's health, pleasure, and autonomy.In this conversation, Patty and Dr. Casperson explore the myths and misinformation that have shaped how menopause is treated, how shame and silence impact care, and what it means to reclaim agency over our bodies as we age. They also discuss the significance of the FDA's removal of black box warnings on vaginal estrogen, why that decision matters for patient safety and access, and how evidence-based care can radically improve quality of life.This episode is both practical and affirming, grounded in science, lived experience, and the belief that sex care is self care at every stage of life.https://www.sheplusfoundation.com/https://kellycaspersonmd.com/the-menopause-moment-book/

00:00:00 – Podcast "tension" backlash and bandmate chemistry 00:04:45 – Claude bot productivity hype and privacy skepticism 00:09:41 – Alex Jones bananas-and-rice clip barrage 00:14:20 – Epstein files and Israel intel-spy framing 00:19:04 – "Epstein was Russian" media spin and Simpsons island joke 00:24:03 – Gates reacts to Epstein links and "just dinners" defense 00:28:51 – Charlie Kirk death theories and pro-Israel donor pressure talk 00:33:54 – Ted Cruz clip sparks "patterns" debate 00:38:55 – Pizzagate re-litigation and Ben Swann vindication lap 00:42:30 – Disturbing child-abuse testimony clips discussion 00:52:02 – Epstein ranch email claims and "where are the bodies" angle 00:56:03 – Netanyahu travel-email coincidence breakdown 01:00:15 – Kash Patel teases more on the Butler shooter, still opaque 01:09:26 – Trump rumored alien disclosure speech tied to Roswell date 01:19:07 – Human skull donated to Goodwill mystery 01:23:57 – Coffee contamination: cockroach bits within FDA limits 01:28:43 – ScotRail mocked-up train image accused of fascist logo reuse 01:37:46 – Blowtorch roof-ice removal sets house on fire 01:42:41 – Heinz ketchup keg gimmick and "link in bio" annoyance 01:47:41 – IKEA's absurd 20-inch hot dog showdown 01:56:12 – Lobster weather forecaster, plugs, and sign-off chatter Copyright Disclaimer Under Section 107 of the Copyright Act 1976, allowance is made for "fair use" for purposes such as criticism, comment, news reporting, teaching, scholarship, and research ▀▄▀▄▀ CONTACT LINKS ▀▄▀▄▀ ► Website: http://obdmpod.com ► Twitch: https://www.twitch.tv/obdmpod ► Full Videos at Odysee: https://odysee.com/@obdm:0 ► Twitter: https://twitter.com/obdmpod ► Instagram: obdmpod ► Email: ourbigdumbmouth at gmail ► RSS: http://ourbigdumbmouth.libsyn.com/rss ► iTunes: https://itunes.apple.com/us/podcast/our-big-dumb-mouth/id261189509?mt=2    

Two very different challenges, and one shared public health reality: systems have to work when it matters most.  In this episode, we speak with Dr. Erica Pan, director and state public health officer for the California Department of Public Health, and ASTHO member, about a rare and unprecedented infant botulism outbreak linked to contaminated infant formula. She explains how California's unique Baby BIG® treatment program, home to the only infant botulism treatment in the world, helped detect a national pattern, how states coordinated with CDC and FDA, and the logistical strain of managing treatment supply, clinician hotlines, and public communication during a fast-moving emergency.  Then, Alex Wheatley, senior director of island support at ASTHO, joins us to discuss a different kind of pressure point: helping U.S. Island jurisdictions navigate complex federal grant systems. She outlines a new resource designed to bridge gaps between federal funders and local health agencies, reduce misunderstandings, and build stronger, trust-based partnerships, especially when timelines, administrative processes, and time zones don't align.State Health Agencies' Role in Implementing Pharmacist-Prescribed Contraception | ASTHOWebinar Registration - Zoom

If you like this podcast, please share it on your social channels. You can also subscribe to the series and check out all of our episodes at www.osmosis.org/podcast

On this episode of Vitality Radio, we continue Formula Face Off with a deep dive into two popular microbiome gummies from Lemme—one designed for bloating and digestion, and the other positioned for daily immune support. Rather than judging hype or branding, we go straight to what matters most: the Supplement Facts panel. You'll learn why probiotic strains, CFU transparency, dosing formats, and ingredient compatibility matter far more than marketing claims. We break down probiotics vs. postbiotics, explain when spore-based strains make sense in gummies, and expose common examples of “window dressing” ingredients that look impressive but fall short of clinical relevance. We also discuss essential cofactors like vitamin K2, magnesium, and copper—and why their absence can undermine otherwise solid formulas. The goal here, as always, is to help you become a smarter, more confident supplement consumer.Products:Back on TractPrecision Probiotic Vital SporesNordic Naturals Probiotic GummiesVitality Radio POW! Product of the Week: Ridgecrest Herbals Hair Revive and Hairs a Million Nutrient Infused Hair Serum $59.99 for the combo ($40 savings off full retail!) with PROMO CODE: POW26Additional Information:#609: Formula Face Off: Sleep, Metabolism & Libido Gummies - Do They Actually Work?Visit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In this episode, Danielle shares her heartbreaking journey from a dedicated hospice nurse to a vaccine injury survivor, detailing the devastating impact of the COVID-19 vaccine on her health, career, and family. She joins us from her hospital room as she fights not only for her life, but for justice, for help in covering the treatment that is actually keeping her out of Hospice (yes, Hospice!), and for the acknowledgement from the government, the medical community, and insurance companies, some of whom STILL will not acknowledge the cause of her injuries. Her story underscores the urgent need for recognition, support, and systemic reform, and we encourage everyone to listen, to share, and to go to www.react19.org to help Danielle and thousands like here who need us. Timestamps00:00 - Introduction and Danielle's background as a hospice nurse 02:11 - Danielle's testimony to the FDA and life-changing vaccine injury 04:46 - The story behind Danielle's decision to get vaccinated 08:07 - The progression of her health decline over four years 09:51 - The systemic neglect and lack of treatment options 12:54 - The role of organizations like React 19 in finding help 15:16 - The importance of recognition and medical advocacy 17:04 - The treatment: IVIG, costs, and barriers to access 20:21 - The ongoing fight for medical acknowledgment and insurance coverage 23:36 - The necessity of treatments like IVIG for survival 26:14 - Systemic failures and the need for reform in healthcare and insurance 28:37 - The mental health toll and community support 31:01 - Danielle's heartfelt letter to her son and the personal toll 32:25 - The call to action: educate, donate, share, and advocate 34:30 - The importance of community and systemic change 37:00 - Sharing stories to create awareness and push for justice 40:26 - The ongoing hope for healing and systemic acknowledgment 43:11 - Connecting with Danielle: social media and activism 44:03 - Closing remarks and encouragement to spread awarenessResources & Linkswww.React19,orgDanielle's Twitter - @thecoercednurseJust Think: The Podcast on Instagram - JustThink_ThePodcastSupport the CausePlease visit React 19 to learn more, donate, and share Danielle's story. Your support can help bring systemic change and provide life-saving treatments for vaccine-injured individuals.

Have you noticed that our food pyramid looks a little different? With the FDA's 2026 release of the updated food pyramid and dietary guidelines, Jenn is here to unpack why these changes matter and what they might mean for your health and your plate. In this episode, host and health coach, Jenn Trepeck breaks down the controversial new dietary guidelines released by the FDA in 2026. From the seemingly dramatic increase in protein and dairy intake recommendations to her concerns about food quantity versus quality, what do these changes mean for us on an individual level or for our families? Jenn also discusses the massive implications for millions of Americans that rely on federal nutrition programs such as school lunch programs, SNAP benefits, the WIC program, and military meals. With the slogan “Make America Healthy Again” Jenn breaks down the resources to discern whether these new guidelines are based on evidence-based research or meat and dairy industry influence. Remember, nutrition is nuanced and individualized, there is not a “one-size-fits-all” dietary plan. What You Will Learn in This Episode:✅ Why the new dietary guidelines impact millions of Americans through federal nutrition programs, including the school lunch program, SNAP benefits, and the WIC program, and how these changes will affect meal planning for the most vulnerable populations✅ The controversial shift in protein recommendations from 0.8 to 1.2 to 1.6 grams per kilogram, and why this increase raises questions about evidence-based nutrition versus food industry influence✅ The critical difference between public health recommendations and individual health needs, and why understanding this distinction is essential for making informed nutrition education decisions✅ How the removal of the health equity lens and emphasis on red meat consumption without addressing food quality concerns demonstrates the challenge of creating truly comprehensive nutrition standardsThe Salad With a Side of Fries podcast, hosted by Jenn Trepeck, explores real-life wellness and weight-loss topics, debunking myths, misinformation, and flawed science surrounding nutrition and the food industry. Let's dive into wellness and weight loss for real life, including drinking, eating out, and skipping the grocery store.TIMESTAMPS: 00:00 Federal nutrition programs, why dietary guidelines feed students with varied nutrients from different food groups01:48 New nutrition guidelines and the confusion that comes with the updated food pyramid 07:41 Why these dietary guidelines matter for military food assistance, school meals, and other federal nutrition programs 11:19 Statistics reveal 6.7 million on WIC, 41.7 million on SNAP benefits, and 30 million students receive school lunch nationwide15:39 Breaking down the upside-down food pyramid showing meat and dairy at the top, vegetables and fruit in the middle, and whole grains at the bottom21:26 Discussion on food industry funding and which beef, pork, and dairy associations paid dietary guideline committee members24:15 Protein recommendations increase without any mention of food quality or emphasizing plant protein sources like legumes and beans30:27 The recommendation of three servings of dairy per day ignores lactose intolerance and possible health impacts of dairy32:53 Only three servings of vegetables recommended per day equals the same amount as dairy servings36:18 Saturated fat capped at 10% creates a puzzle when combined with increased red meat consumption without quality considerations41:15: Whole grains recommendation of two to four servings a day44:01 Bottom line recommendations from the new guidelines assessmentKEY TAKEAWAYS:

This week, we look at new evidence on oral cholesterol-lowering therapy, the evolving role of beta-blockers after myocardial infarction, and advances in breast and prostate cancer treatment. We review the inherited risk of coronary disease. We also work through a revealing diagnostic case in a young woman and reflect on science under pressure, corporatized insurance, the reach of FDA law, and what it means to live with life-sustaining technology.

In Part 2 of the conversation with Dr. Peter Staats, the discussion expands beyond clinical medicine into leadership, advocacy, entrepreneurship, and the business realities shaping modern healthcare. Dr. Staats reflects on his extensive involvement in professional medical societies, explaining how each organization served a different mission—from physician advocacy and scientific advancement to global education and charitable efforts aimed at improving standards of pain care worldwide. The episode also explores Dr. Staats' entrepreneurial journey, including the founding of electroCore and his work in non-invasive vagus nerve stimulation. He candidly describes the challenges of bringing innovation to market, particularly the long and often frustrating path from FDA approval to insurance reimbursement. His experience highlights the significant risks, persistence, and strategic partnerships required to translate medical innovation into widely accessible patient care. Finally, Dr. Staats shares lessons from building and scaling large physician practices, navigating mergers and private equity, and balancing clinical integrity with executive decision-making. He concludes with guidance for younger physicians, emphasizing that long-term success comes from maintaining patient-centered values, protecting one's integrity, and approaching business opportunities thoughtfully rather than chasing short-term financial gain. Learn more, including additional show notes, links, and detailed key takeaways, by visiting physicianswealthpodcast.com. Click here to get your FREE copy of our latest book, Wealth Strategies for Today's Physician!

Wearables are no longer just fitness gadgets. They're becoming clinical-grade health tools, and healthcare has a lot to learn from that journey. In this episode, we sit down with Marco Benitez, CEO and Founder of ROOK, to explore how wearable technology is transforming preventive care through real-world insights and patient engagement. Watch the video version here. We discuss: The evolution of wearables from fitness trackers to FDA-approved, clinical-grade tools Why accuracy, validation, and data quality are essential for healthcare adoption How continuous, 24/7 behavioral data reveals patterns linked to health and disease The role of data standardization in building trustworthy AI in healthcare What healthcare can learn from consumer engagement in fitness and longevity platforms How connecting fitness, health, and insurance can unlock real innovation in preventive care This conversation is essential for healthcare executives, digital health leaders, payers, clinicians, and anyone thinking about the future of AI-driven, patient-centered care. Connect with Marco on Linkedin at https://www.linkedin.com/in/marcobzg Find Marco's work at https://www.tryrook.io Subscribe and stay at the forefront of the digital healthcare revolution. Find out why we're the fastest growing digital health channel on YouTube!  The Digital Healthcare Experience is a hub to connect healthcare leaders and tech enthusiasts. Powered by Taylor Healthcare, this podcast is your gateway to the latest trends and breakthroughs in digital health. Learn more at taylor.com/digital-healthcare About Us: Taylor Healthcare empowers healthcare organizations to thrive in the digital world. Our technology streamlines critical workflows such as procedural & surgical informed consent with patented mobile signature capture, ransomware downtime mitigation, patient engagement and more. For more information, please visit imedhealth.com   The Digital Healthcare Experience Podcast: Powered by Taylor Healthcare Produced by Naomi Schwimmer  Hosted by Chris Civitarese Edited by Eli Banks Music by Nicholas Bach  

Dear Dr. Whiffenschtuppel, I write to you this day to express my deepest gratitude for changing my life. Long ago, I remember staring at my banana on the kitchen counter, bruised and drooping with despair; a perfect reflection of my life before Bocox. Every day felt soft, sad, and permanently past its prime. I meandered through my days burdened with shame and grief, wondering how something once so full of potential and promise could end up so utterly limp and forgotten; pushed to the back of the proverbial kitchen drawer of existence, right behind an old D battery. Then Bocox entered my life and somehow, miraculously, my banana stood tall again; firm with hope and glowing with newfound confidence. Each and every morning I gaze down at it, radiant and renewed as tears well in my eyes. Because Bocox didn't just save my banana, it gave it an unflappable, tumescent second chance. XOXO, Katya Z. You're going to love Hungryroot as much as we do! For a limited time, get 40% off your first box PLUS get a free item in every box for life! Go to: https://Hungryroot.com/BALD and use code BALD This episode is sponsored by BetterHelp! Sign up and get 10% off at: https://BetterHelp.com/BALD Ro offers the first FDA-approved GLP-1 pill for weight loss at the lowest cost around! To see if you're eligible for the new GLP-1 pill on Ro, head to: ⁠https://Ro.co/BALD⁠ Get a free can of OLIPOP! Buy any 2 cans of Olipop in store, and Olipop will pay you back for one! Works on any flavor, any retailer. Head to: https://Drinkolipop.com/BALD Getting contacts doesn't have to be a hassle. Let 1-800 Contacts get you the contact lenses you need right now. Order online at https://1800Contacts.com or download the free 1-800 Contacts app today! Follow Trixie: @TrixieMattel Follow Katya: @Katya_Zamo To watch the podcast on YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/TrixieKatyaYT⁠⁠⁠⁠⁠ To check out our official YouTube Clips Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/TrixieAndKatyaClipYT⁠⁠⁠⁠⁠ Don't forget to follow the podcast for free wherever you're listening or by using this link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/thebaldandthebeautifulpodcast⁠⁠⁠⁠⁠ If you want to support the show, and get all the episodes ad-free go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thebaldandthebeautiful.supercast.com⁠⁠⁠⁠⁠ To check out future Live Podcast Shows, go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://trixieandkatya.com/#tour⁠⁠⁠⁠⁠ To check out the Trixie Motel in Palm Springs, CA: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemotel.com⁠⁠⁠⁠⁠ Listen and Watch Anywhere! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/thebaldandthebeautifulpodcast⁠⁠⁠⁠⁠ Follow Trixie: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemattel.com⁠⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@trixie⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/trixiemattel⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/trixiemattel⁠⁠⁠⁠⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/trixiemattel⁠⁠⁠⁠⁠   Follow Katya: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.welovekatya.com⁠⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@katya_zamo⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/welovekatya⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/katya_zamo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/katya_zamo⁠⁠⁠⁠⁠   #TrixieMattel #KatyaZamo #BaldBeautiful Learn more about your ad choices. Visit podcastchoices.com/adchoices

How could Lexie not know that she was black?  And when the secret was revealed it nearly shattered her world. It's a complicated story of family, secrets and broken trust. DRIP DROP Get 20% off your first order: dripdrop.com and use promo code secret. HERS Thank you, HERS! Go to forhers.com/SECRET for your personalized weight loss treatment options. Weight Loss by Hers is not available everywhere. Compounded products are not approved or reviewed for safety, effectiveness, or quality by the FDA. Prescription required. See website for full details, important safety information, and restrictions. Actual price depends on product and plan purchased. MINT MOBILE Get unlimited premium wireless for just $15 per month. Make the switch! MINTMOBILE.com/SECRET WILD GRAIN Get $30 off your first box + free Croissants in every box. Go to wildgrain.com/SECRET to start your subscription. PICTURES See pictures of Lexie and her fam now. Also see the the picture of Lexie's mom and her bio dad her grandfather showed her They are waiting for you on Threads, Facebook, Instagram and X.  Handle: @secretroompod. YOUTUBE You can listen to The Secret Room now on YouTube! THE SECRET ROOM | UNLOCKED Deja, like Lexie on today's show, is black and raised by white parents. But her experience was different. On the outside she seemed like the perfect pastor's kid. But her secret was that on the inside she was living in conflict with everything she was taught and never knew how to make all of those pieces fit together.  Host: Susie Lark. The Secret Room | Unlocked is yours when you support your favorite indie podcast that could with a membership at patreon.com/secretroom, Apple Podcasts or Spotify. There's a free trial! ALL OUR SPONSORS See all our sponsors past and present, and their offers, many of which are still valid: secretroompodcast.com/codes  FACEBOOK DISCUSSION GROUPThere's even more fun at The Secret Room Podcast Facebook Discussion Page!  Just ask to join, all are welcome. :) YOUR SECRET  Click "Share a Secret" at secretroompod.com! PODCAST TEAM Producer: Susie Lark. Story Development: Luna Patel. Music and Theme: Breakmaster Cylinder. LISTENER SURVEY Take our Listener Survey at SecretRoomPod.com!

What if growth isn't about pushing harder, but about letting go more skillfully? In this episode of Why Isn't Everyone Doing This?, Emily sits down with coach and author Suzy Ashworth for a grounded, activating conversation about identity shifts, pivots, and what it actually takes to receive more in life and business. Together, they explore why true transformation doesn't come from strategy alone, but from who you're willing to become in your body, your nervous system, and your sense of self. Suzy shares how the most powerful pivots in her life and work didn't come from forcing outcomes, but from releasing attachment to timelines, outcomes, and the need to prove. They unpack the difference between desire and striving, why pleasure and joy create magnetism, and how detachment becomes a superpower when it comes to manifestation and receiving. This conversation reframes success as an internal orientation first, and an external result second. This episode is for anyone standing at the edge of a change, sensing that the next level requires less effort and more trust, and learning how to open themselves to receive what's already available. KEY MOMENTS: 00:00:00 — Identity as the starting point of transformation 00:03:15 — Setting the energetic field: invocation, coherence, intention 00:07:00 — Why the pivot matters more than the plan 00:11:20 — Joy and pleasure as stabilizers for growth 00:18:10 — Choosing who you become when life forces a reckoning 00:24:30 — Resilience, failure, and expanding emotional capacity 00:27:00 — Detachment as a manifestation superpower 00:31:00 — Faith plus action: alignment without exhaustion 00:34:00 — Identity before income and external results 00:46:00 — Integration: when the work becomes how you live About Suzy Ashworth Suzy Ashworth is a coach, speaker, and bestselling author of Infinite Receiving. She is the founder of the Quantum Leap Your Life & Business certification and works with leaders and entrepreneurs who are ready to shift identity, expand capacity, and build success that is both profitable and sustainable. Suzy's work focuses on embodiment, nervous system alignment, and redefining success as something that is lived, not chased. Learn more about Suzy and explore her work:https://suzyashworth.com Follow Suzy on Instagram:https://www.instagram.com/suzy_ashworth For Those Ready to Hold More The themes in this episode, alignment, capacity, faith plus action, and leadership without burnout, are exactly what Level 3 is designed to support. It's where the work stops being something you do in moments of stress and becomes the way you lead, decide, and steward what you're responsible for. By working at the level of the nervous system, state of consciousness, and capacity to hold more, Level 3 supports the kind of embodied leadership Suzy speaks to in this episode, abundance that lasts without exhaustion.

Two years ago the FDA pulled down just about every insulin calculator app. A lot of them just disappeared, rather than seek official approval, but one of them – created by a teenager with type 1 – is back. I'm talking with Drew and Mike Mendelow about the relaunch of T1D1, a free and ad-free insulin-dose calculator app. They share what it was like to navigate the FDA process, how they go international help, and what's next. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Announcing Community Commericals! Learn how to get your message on the show here. Learn more about studies and research at Thrivable here Please visit our Sponsors & Partners - they help make the show possible! Omnipod - Simplify Life All about Dexcom  All about VIVI Cap to protect your insulin from extreme temperatures The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com 

Big pharma and biotech take the earnings stage this week with reports from Eli Lilly (NYSE: LLNY) and Novo Nordisk (NYSE: NVO) leading the lineup. Will they help the industry once again outperform AI champ NVIDIA (NASDAQ: NVDA), as the industry did in 2025? Karl Thiel, Tom King, and Tim Beyers discuss: - Slow rolling chaos at FDA and its effects on drug approvals. - How to think about risk when investing in biotech. - Earnings predictions for Lilly and Novo as well as a review of results from DNA researcher Twist Bioscience (NASDAQ: TWST). Don't wait! Be sure to get to your local bookstore and pick up a copy of David's Gardner's new book — Rule Breaker Investing: How to Pick the Best Stocks of the Future and Build Lasting Wealth. It's on shelves now; get it before it's gone! Companies discussed: RGNX, LLY, NVO, TWST Host: Tim Beyers Guests: Karl Thiel, Tom King Producer: Anand Chokkavelu Engineer: Dan Boyd Disclosure: Advertisements are sponsored content and provided for informational purposes only. The Motley Fool and its affiliates (collectively, “TMF”) do not endorse, recommend, or verify the accuracy or completeness of the statements made within advertisements. TMF is not involved in the offer, sale, or solicitation of any securities advertised herein and makes no representations regarding the suitability, or risks associated with any investment opportunity presented. Investors should conduct their own due diligence and consult with legal, tax, and financial advisors before making any investment decisions. TMF assumes no responsibility for any losses or damages arising from this advertisement. We're committed to transparency: All personal opinions in advertisements from Fools are their own. The product advertised in this episode was loaned to TMF and was returned after a test period or the product advertised in this episode was purchased by TMF. Advertiser has paid for the sponsorship of this episode. Learn more about your ad choices. Visit ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

Stories from a Giant and Gadfly Discover the Protest Music of RainFall!-- like "The Antidepressant Blues!" Today, we are delighted to spend some time with a dear friend and highly esteemed colleague, Dr. David Antonuccio. David is a retired Clinical Psychologist and Professor Emeritus in the Dept. of Psychiatry and Behavioral Sciences at the University of Nevada, Reno, School of Medicine. In addition to his academic work, David had his own clinical practice for 40 years. He has published over 100 academic articles and multiple books, primarily on the treatment of depression, anxiety, or smoking cessation. Since his retirement from practice in 2020, he has been making music as part of a duo called RainFall, with his musical partner Michael Pierce. Their music can be found on Spotify, Apple music, and Soundcloud, among other streaming services. I first became familiar with David when a colleague recommended his article entitled: "Psychotherapy versus medication for depression: challenging the conventional wisdom with data," which was published in Professional Psychology: Research and Practice way back in 1995. The article blew my socks off. In the first place, he had come to the many of the same conclusions I had come to, that antidepressants had few "real" effects above and beyond their placebo effects. However, he also had incredible insights into some of the problems and loopholes with drug company research studies on antidepressants, so I tried to get as many colleagues and students as possible to read that article. Here is the article link Although I had never met David, he became my hero. One day, while I was giving one of my two-day CBT workshops in Nevada, I was singing his praises and urging participants to read that classic article, but, unexpectedly, some people started chuckling. At a break, I asked someone why people had been laughing. They said, "Didn't you know that David Antonuccio is here attending this workshop? He was out visiting the bathroom when you were singing his praises, so he didn't hear you!" And that's how we met! I couldn't believe my good fortune in meeting this brilliant and humble man in person. And to my good fortune, we became good friends right off the bat and eventually did a lot of fun professional work together, like our exciting conference challenging the chemical imbalance theory of depression which we called the Rumble in Reno. I was also proud to be included as a co-author in a popular article with David and William Danton reviewing the brilliant work of Irving Kirsch. Kirsch had re-analyzed all the data on antidepressants in the FDA archives and concluded that the chemicals called "antidepressants" had few, if any, clinically significant effects above and beyond their placebo effects. In that paper, we also emphasized the ongoing power struggle between the needs of science and the needs of marketing. Science is devoted to discovering and reporting the truth, based on research, regardless of where it leads, while marketing, sadly, is ultimately loyal to the bottom line, even if deception is required. Here is the link to our article: And here is the full reference: Antonuccio, D. O., Burns, D., & Danton, W. G. (2002). Antidepressants: A Triumph of Marketing over Science? Prevention and Treatment, 5, Article 25. Web link: http://journals.apa.org/prevention/volume5/toc-jul15-02.htm I was sad when David retired from his clinical, teaching, and research career a number of years ago in order to spend more time on creating and recording music because, a passion he'd put on the shelf during the most active years of his career. I felt we'd lost an important and courageous leader in the behavioral sciences, and felt an emptiness, like an important pioneer was suddenly missing. The following link provides a highly readable brief overview of David's career focus and interests. I was thrilled to learn just recently that David has partly resumed his role as gadfly of the behavioral sciences, rejoining the fight for science, ethics and for truth, regardless of where that leads or whose feathers are ruffled. And now, we sit down together to reminisce about his personal life and experiences with many of the greats in our field, like Dr. David Healey, Irving Kirsch, and others who have also stood up for the truth, based on their research, in spite of intense opposition from the establishment. And, today David also brings us his music, with his colleague, Michael Pierce, RainFall. Some of his music has psychiatric / psychological themes, like his "Antidepressant Blues," Some of David's music has humanistic and political themes. He said: Here's a song we just released yesterday that i will assume would not be relevant to the podcast. It is called Final Embrace and was inspired by a heart-breaking international wire photo of a Salvadoran immigrant father hugging his daughter, both deceased, in the rio grande in 2019. Here's the link to the original news story. David's two-man group, RainFall, wrote and recorded the original acoustic version of this song in 2020. He explains: We decided to record a more dynamic updated version of the song with some electric guitar chords, electric bass, and drums. We are calling it "Final Embrace Electric". The story is still heart-breaking, and it still makes me cry to sing it. Here is a link to the new version of the song, And here are the heart-breaking lyrics: Final Embrace Electric (For Oscar and Valeria) By RainFall (David Antonuccio and Michael Pierce) I'm sorry I couldn't help you I'm sorry you lost your life You took a deadly risk I'm sorry for your wife What were you supposed to do? Stay home and watch your family die? Or take a chance at freedom Reach for the sky Some say you should have known better They say that you are a criminal But they don't know your fear, your pain, your hunger For them it's the principle Some say we were here first It's not our problem Despite your dire thirst We're full, no more asylum Let's ask them what they would do If their family were faced with danger If they're honest, they'd take the chance Hope for kindness from a stranger You tried to get in the front door But it was slammed closed So you swam the deadly current Despite the perilous flow You never lost your grip Though the river was not crossable Only another parent can know How that is even possible Everyone can tell you loved your daughter Even in that place You never let her go It was your final embrace I'm sorry I couldn't help you I'm sorry you lost your life You took a deadly risk I'm so sorry for your wife Everyone can tell you loved your daughter Even in that place You never let her go It was your final embrace Your final embrace It was your final embrace It was your final embrace   Thank you for joining us today. Stayed tuned for Part 2 of the David Antonuccio interview next week! David, Rhonda, and David

We're back with our monthly rundown of the top headlines in health tech!Today, Halle and Steve sort through the biggest stories shaping the year ahead, from AI prescribing to lawsuits galore.We cover:AI prescribing (in Utah!)The FDA updated guidance on clinical decision support for AI in medicineThe lawsuit against Prenuvo after a missed stroke warning, and the broader debate over accountability in AI-assisted diagnosticsTexas' antitrust case against Epic - are they being anti-competitive?New evidence shows GLP-1 drugs lower employer healthcare costs by 9%Why healthcare hiring is slowing downHalle's book is now available! (Order now on Amazon)Show notes:Utah begins pilot of prescribing AI medication (Utah Department of Commerce)FDA issues guidance on wellness products, clinical decision support software (AHA)Man got $2,500 whole-body MRI that found no problems—then had massive stroke (Ars Technica)Texas sues Epic, accusing it of running a monopoly (Wisconsin Public Radio)Why cover GLP-1s? They'll lower employer healthcare costs, study says (Healthcare Dive)Hospitals' make-or-break year (Axios)

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investigational disease-modifying therapies to undergo FDA review.    A Complete Response Letter is an official letter from the FDA to a drug manufacturer stating that the agency can't approve a new medicine in its current form. It's not an outright "no" that kills a project; it's more like a "not yet." However, this Complete Response Letter raised some issues which, at first glance, don't appear to be easily fixable. Sanofi has pointed out that the issues raised in the Complete Response Letter were markedly different from the guidance they received from the FDA over the course of this approval process. Sanofi has also indicated that it would work with the FDA to find a path forward for Tolebrutinib. Dr. William Conte, an MS Specialist and a principal investigator in the Phase 3 clinical trial for Tolebrutinib, has published an article responding to the FDA's Complete Response Letter. This week, Dr. Conte joins me to discuss the FDA's action and his response to that action.  We have a lot to talk about! Are you ready for RealTalk MS??! This Week: We're at the 2026 ACTRIMS Forum  :22 Check out the official ACTRIMS Forum Insider podcast!  :42 The FDA's Complete Response Letter about Tolebrutinib  1:09 Dr. William Conte responds to the FDA's Complete Response Letter  4:09 Share this episode  38:10 Next week's episode  38:30 SHARE THIS EPISODE OF REALTALK MS Just copy this link & paste it into your text or email: https://realtalkms.com/440 ADD YOUR VOICE TO THE CONVERSATION I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts! Email: jon@realtalkms.com Phone: (310) 526-2283 And don't forget to join us in the RealTalk MS Facebook group! LINKS If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com Support Jon at WALK MS https://realtalkms.com/walkms Find out about ABLEnow Accounts https://ablenow.com JOIN: The RealTalk MS Facebook Group https://facebook.com/groups/realtalkms REVIEW: Give RealTalk MS a rating and review http://www.realtalkms.com/review Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com. RealTalk MS Episode 440 Guests: Dr. William Conte Privacy Policy

Are seed oils really that bad? Is it preferable to use beef tallow for frying? Are memory supplements effective? EPA begins review of fluoride in drinking water; FDA issues recall over contaminated supplements; A high lp(a) may call for preventive aspirin use; Arthritis breakthrough as scientists discover way of regenerating joint cartilage; Surprising new findings on coffee, tea consumption, and osteoporosis risk; Skipping breakfast, late dinners may boost fracture risk.

The Derm on RheumNow podcast is a collection of Citations and Content curated for dermatologists – addressing Psoriasis, PsA, CLE, vasculitis, HS, other CTD skin disorders. dermatology drugs, biiologics, JAKs - their use, efficacy and side effects.  Features Dr. Jack Cush, Editor at RheumNow.com.  SHOW NOTES Lupus Accelerating Breakthroughs Consortium commissioned a stakeholders group (including the FDA) to assess drug development in Cutaneous lupus CLE), and they have endorsed CLASI (CLE Dz Area & Severity Index) as the outcome measure for CLE clinical trials. https://t.co/q7If97AHBa PAPA Syndrome: When Sterile Inflammation Mimics Infection (Pyogenic Arthritis, Pyoderma gangrenosum, Acne) •A rare monogenic autoinflammatory disease •Caused by gain-of-function mutations in PSTPIP1

We love to hear from our listeners. Send us a message. On this week's episode of the Business of Biotech, Brian Hilberdink, President of U.S. Human Pharma at Boehringer Ingelheim, returns to the show during the J.P. Morgan Healthcare Conference, and following his departure from LEO Pharma (see episode 164). Brian talks about new opportunities in obesity, the benefits of private ownership in funding early science, Boehringer's deal strategy, using AI to improve commercialization efforts, and the FDA's selection of zongertinib (in patients with HER2-mutant NSCLC) for the Commissioner's National Priority Voucher program.    Access this and hundreds of episodes of the Business of Biotech videocast under the Business of Biotech tab at lifescienceleader.com. Subscribe to our monthly Business of Biotech newsletter. Get in touch with guest and topic suggestions: ben.comer@lifescienceleader.comFind Ben Comer on LinkedIn: https://www.linkedin.com/in/bencomer/

In this Uromigos podcast episode, Brian and Tom engage with Elaine Chang from the FDA to discuss an analysis of depth of response as an indicator of survival in kidney cancer trials. They explore the FDA's data analysis process, the significance of tumor shrinkage, and the implications of their findings on treatment outcomes. The conversation delves into the limitations of current measurement methods and the potential for using depth of response as an early signal in drug development.

Send us a textIn this episode, Dr. Eeks talks with Joel Stanley, entrepreneur and biotech founder, about the long and often misunderstood road from plant based therapies to FDA approved medicines.Joel shares the personal story behind building Charlotte's Web, the company named after a young girl whose experience with severe epilepsy helped spark a global conversation about medical cannabis. He reflects on what it was like to grow a family run operation into a major force that reshaped public perception, while navigating science, regulation, and skepticism.The conversation then turns to Joel's current work at Ajna BioSciences, where he is pursuing FDA approval for botanical drugs, including a botanical-based drug being studied for autism, with trials to be conducted in 2 countries. Joel explains where this research currently sits in the regulatory process and why he has chosen the traditional drug approval route rather than supplements or wellness markets.We also dig into the key differences between botanical drug development and conventional pharmaceutical development, from standardization challenges to clinical trial design, and why plant based medicines are often held to a different and sometimes contradictory standard.Finally, Joel discusses his research into psychedelics, including psilocybin for depression, and why he believes these compounds represent more than a passing trend. This episode is a grounded look at science, policy, and the tension between nature and modern medicine.Work with me? Perhaps we are a good match. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Follow Public Health is WeirdOr Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her WEEKLY newsletter here!Support the show

MANUAL DESCARGAR: https://drive.google.com/file/d/18-eu...Me pueden encontrar tambien en Instagram:   / medhacker  TikTok: https://www.tiktok.com/Compartan si me quieren apoyar! Gracias! ¿Qué es la creatina?-Descubierta en 1832, incluso antes que el ATP.-Es un compuesto nitrogenado que el cuerpo produce en hígado y cerebro.-Se obtiene en pequeñas cantidades de carne y pescado, pero es casi inexistente en dietas vegetarianas o veganas.-Funciona como "el Robin de Batman (ATP)": ayuda a regenerar rápidamente energía para contracciones musculares.Efectos principales en el músculo-Mejora fuerza y rendimiento: más repeticiones, mejor recuperación entre series.-Aumento de masa magra: en promedio 700 g de músculo en 6 semanas.-Recuperación: acelera la reparación muscular y disminuye daño.-Efectos en aeróbicos: ayuda en hidratación y reduce inflamación tras maratones o ironman.-No es un esteroide.Propiedades antiinflamatorias-Reduce citocinas inflamatorias (IL-6, TNF-α, CRP).-Tiene potencial en condiciones donde la inflamación es clave: envejecimiento, sarcopenia, enfermedades neurológicas.-Puede proteger al cerebro en situaciones de estrés metabólico (falta de sueño, jet lag, trauma).Cerebro y cognición-Beneficios en memoria, atención, depresión, Alzheimer, Parkinson y conmociones cerebrales.-Mejora síntomas de privación de sueño y fatiga mental.-En Alzheimer: 20 g/día por 8 semanas mostró mejoría cognitiva.-En depresión: 5 g/día junto con terapia o medicación ayudó a reducir síntomas.Salud ósea-En mujeres postmenopáusicas: 8–12 g/día redujo pérdida de densidad mineral ósea en cadera.-Puede actuar como anti-resortivo, parecido a los bifosfonatos.-Potencial para disminuir riesgo de fracturas y fragilidad.Mujeres, embarazo y niños-Mujeres: suelen tener menores reservas, responden bien a suplementación.-Embarazo: estudios en animales muestran beneficios en placenta y desarrollo fetal; ensayos clínicos en humanos están en curso.-Niños y adolescentes: dosis seguras (0.1 g/kg). Evidencia positiva en deportes y en casos de conmoción cerebral.Dosis y formas de uso-Estándar: 3–5 g/día.-Carga rápida: 20 g/día (divididos) por 5–7 días, luego 3–5 g/día.-Enfocado en cerebro: más de 10 g/día, incluso hasta 20 g en patologías como Alzheimer.-Se puede tomar con comida (mejor absorción con proteínas o carbohidratos).-No importa la hora: lo clave es la consistencia.Mitos y realidades-Daño renal: falso (creatinina puede subir, pero es marcador falso).-Hipertensión: no aumenta la presión arterial.-Retención de líquidos peligrosa: la hidratación es intracelular y benéfica.-Pérdida de cabello: no hay evidencia.-Engorda: al contrario, puede favorecer leve pérdida de grasa.-Necesidad de ciclo: no es necesario suspender.Seguridad-Considerado por la FDA como “Generally Recognized as Safe (GRAS)”.-Más de 1000 estudios respaldan su seguridad y eficacia.-Puede usarse en jóvenes, adultos, mujeres y mayores.Futuras áreas de investigación-Uso en cáncer, tanto en prevención como adyuvante en tratamientos.-Embarazo y lactancia: estudios en humanos en curso.-Trastornos neurológicos y psiquiátricos: depresión, ansiedad, PTSD, ADHD.Recomendaciones prácticas-Base de salud: ejercicio + sueño + buena nutrición.-Creatina es “la cereza del pastel”: segura, económica y altamente estudiada.-Idealmente acompañada de entrenamiento de fuerza y suficiente ingesta proteica.-En pacientes que usan GLP-1 (semaglutide, tirzepatide): fundamental para evitar pérdida de músculo.

This album started as a family project and turned into a Grammy nomination. The internet rallied behind a 92-year-old woman still working to make ends meet. An FDA-cleared brain treatment is offering hope to people with depression who've tried everything else. Meet the crew tasked with fighting and preventing wildfire disasters in Los Angeles. Plus, these divers rescued a ray and what happened next shocked them.  Sign up for the CNN 5 Good Things newsletter here.  Host/Producer: Krista Bo Polanco  Showrunner: Faiz Jamil  Senior Producer: Felicia Patinkin  Editorial Support: Dan Bloom, Cindy Von Quednow, Hyan de Freitas Learn more about your ad choices. Visit podcastchoices.com/adchoices

On this episode of Vitality Radio, Jared introduces another new series and walks listeners through a real-world supplement label breakdown using popular gummy products found in big-box stores. Instead of focusing on hype, Jared teaches how to read ingredient panels, understand dosing, and recognize the difference between marketing and meaningful formulation. He compares sleep, metabolism, and libido gummies and explains why milligrams, extract ratios, and standardization matter when choosing supplements. This episode is less about criticizing brands and more about empowering you to become a smarter, more informed consumer. You'll learn what makes a formula physiologically relevant, what “window dressing” looks like on a label, and how to think critically about supplements marketed for sleep, weight management, and sexual wellness.Products:Vital SleepLifeSeasons Metabolism Weight ManagementOmneDiem Thermogenic Weight LossTerry Naturally Red Ginseng Female Sexual EnhancementMan-Up Male Performance Nitric Oxide FormulaVisit the podcast website here: VitalityRadio.comYou can follow @vitalitynutritionbountiful and @vitalityradio on Instagram, or Vitality Radio and Vitality Nutrition on Facebook. Join us also in the Vitality Radio Podcast Listener Community on Facebook. Shop the products that Jared mentions at vitalitynutrition.com. Let us know your thoughts about this episode using the hashtag #vitalityradio and please rate and review us on Apple Podcasts. Thank you!Just a reminder that this podcast is for educational purposes only. The FDA has not evaluated the podcast. The information is not intended to diagnose, treat, cure, or prevent any disease. The advice given is not intended to replace the advice of your medical professional.

In the late 1990s, a strange carbon molecule quietly delivered the single longest lifespan extension ever recorded in mammals. The rats lived about 90% longer, and almost no one was paying attention. This episode breaks down what that molecule is, why it works, and how it may upgrade mitochondria, sleep, and human performance when used correctly. Watch this episode on YouTube for the full video experience: https://www.youtube.com/@DaveAspreyBPR Host Dave Asprey sits down with Chris Burres, founder and chief scientist of MyVitalC and the original long-term manufacturer of carbon 60. Chris has produced this Nobel Prize–winning molecule since the early 1990s, supplying research institutions around the world years before it ever entered the biohacking space. He explains how carbon 60 behaves differently from traditional antioxidants, why stability and concentration used to be major problems, and how modern manufacturing finally made real-world use possible. Chris is also a published author, longevity summit host, patent holder, and longtime science communicator who brings rare clarity and humor to complex biology. Dave and Chris explore how carbon 60 interacts with mitochondria, oxidative stress, metabolism, and electrical signaling in the body, and where it fits alongside ketosis, nootropics, supplements, and functional medicine strategies. They also unpack why improving mitochondrial function often shows up first as better energy and sleep optimization, and how that foundation supports longevity, brain optimization, and Smarter Not Harder performance. Along the way, Dave shares his own early experience with C60, how he uses it today, and why it now shows up even in his Danger Coffee stack. You'll Learn: • Why carbon 60 produced the longest longevity result ever recorded in mammal studies • How mitochondrial efficiency shapes energy, sleep, and human performance • What makes C60 a selective antioxidant instead of a blunt one • Why purity, concentration, and stability determine whether a supplement works • How carbon 60 fits into biohacking stacks built around ketosis and metabolism • What users report first, from focus and resilience to deeper sleep • Why mitochondrial health underpins long-term anti-aging strategies • How to think about supplements through a Smarter Not Harder lens Dave Asprey is a four time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade is the top podcast for people who want to take control of their biology, extend their longevity, and optimize every system in the body and mind. Each episode features cutting edge insights in health, performance, neuroscience, supplements, nutrition, hacking, emotional intelligence, and conscious living. Affiliates: Vibrant Blue Oils | Grab a full-size bottle for over 50% off at https://vibrantblueoils.com/dave. ECHO Water | Go to http://echowater.com/dave and use code DAVE10 for 10% off your ECHO Flask. Dave Asprey is a four-time New York Times bestselling author, founder of Bulletproof Coffee, and the father of biohacking. With over 1,000 interviews and 1 million monthly listeners, The Human Upgrade brings you the knowledge to take control of your biology, extend your longevity, and optimize every system in your body and mind. Each episode delivers cutting-edge insights in health, performance, neuroscience, supplements, nutrition, biohacking, emotional intelligence, and conscious living. New episodes are released every Tuesday, Thursday, Friday, and Sunday (BONUS). Dave asks the questions no one else will and gives you real tools to become stronger, smarter, and more resilient. Keywords: carbon 60 podcast, C60 longevity science, biohacking mitochondria, mitochondrial optimization podcast, anti-aging supplements science, human performance longevity, selective antioxidant mitochondria, sleep optimization biohacking, brain optimization supplements, nootropics longevity stack, ketosis metabolism longevity, functional medicine mitochondria, oxidative stress longevity, carbon 60 supplement science, MyVitalC podcast, Chris Burres interview, Dave Asprey biohacking, Danger Coffee stack, Smarter Not Harder longevity, Nobel Prize molecule longevity, mitochondrial health podcast Resources: • Get a 30% discount on your next purchase of ESS60 at: https://www.myvitalc.com/pages/humanupgradeod?ref=humanupgrade • Get My 2026 Biohacking Trends Report: https://daveasprey.com/2026-biohacking-trends-report/ • Join My Low-Oxalate 30-Day Challenge: https://daveasprey.com/2026-low-ox-reset/ • Dave Asprey's Latest News | Go to https://daveasprey.com/ to join Inside Track today. • Danger Coffee: https://dangercoffee.com/discount/dave15 • My Daily Supplements: SuppGrade Labs (15% Off) • Favorite Blue Light Blocking Glasses: TrueDark (15% Off) • Dave Asprey's BEYOND Conference: https://beyondconference.com • Dave Asprey's New Book – Heavily Meditated: https://daveasprey.com/heavily-meditated • Upgrade Collective: https://www.ourupgradecollective.com • Upgrade Labs: https://upgradelabs.com Timestamps: 0:00 – Introduction & C60 Discovery 4:04 – The Molecule & Nobel Prize 8:27 – Quantum Properties & Superconductivity 11:16 – Rat Longevity Study Results 14:33 – Selective Antioxidant Properties 15:51 – User Experience & Timeline 18:15 – Biological Age Testing 21:33 – Why Oil & Product Development 23:32 – Mechanism of Action 28:13 – Biohacker Discovery Story 30:03 – FDA & Supplement Regulation 33:50 – Migraines & Clinical Observations 37:53 – Athletic Performance 40:43 – Stacking & Contraindications 45:57 – Skincare Product 50:43 – Who Benefits Most 1:00:37 – Mitochondria & Consciousness 1:02:03 – Where to Buy & Closing See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join me for an inspiring conversation with Shelly Garg, the founder of Wave Kids and a seasoned FDA attorney, as she shares her journey of creating the first kids' lifestyle and beverage brand focused on building better hydration habits. Shelly's passion for children's health shines through as she discusses her mission to provide a fun, trustworthy alternative to the sugary, artificial drinks that dominate the market. She offers profound insights into the "wave of change" she is spearheading, moving away from high-fructose corn syrup and hidden caffeine toward products that parents can feel good about and kids genuinely enjoy. Shelly explains how her background in food and drug law, combined with the raw reality of motherhood, fueled her desire to flip the traditional industry model on its head. Explore how Shelly is bringing magic to hydration through innovative, temperature-activated color-changing cans and playful artwork created by children themselves. She outlines the challenges of scaling a small business while remaining committed to accessibility, ensuring that healthy options aren't restricted by a family's socioeconomic status. Listen in as she discusses the future of Wave Kids, including plans to expand into national retail and introduce organic, fruit-flavored waters with natural electrolytes. The episode concludes with a poignant reflection on empowerment, where Shelly emphasizes the importance of living in alignment with one's values and the transformative power of choosing a bigger "why" for the sake of the next generation. Connect with Shelly:Website: www.wave-kids.com Instagram: @hellowavekids Let's keep the conversation going!Website: www.martaspirk.com Instagram: @martaspirk Facebook: Marta Spirk Want to be my next guest on The Empowered Woman Podcast?Apply here: www.martaspirk.com/podcastguest  Watch my TEDx talk: www.martaspirk.com/keynoteconcerts      There's a reason Pitch Worthy is on every power founder's radar. It's the definitive PR book for women done with being overlooked. If you're ready for press, premium clients, and undeniable authority, this is your playbook. Buy your copy now at hearsayPR.com.  

What did the FDA just recall? Also, is this the worst coworker ever? We talk about Joe Rogan announcing why he didn't get nominated for a Golden Globe, new pot pie from KFC, and lots more!

On today's episode, content creator and mama of three Ruby Smoot gets real about the parts of infertility and pregnancy after infertility we don't talk about enough — the mental health spiral, the obsessive thoughts, the fear, and the quiet, heavy darkness that can creep in while you're trying so hard to become a parent. In this deeply candid conversation, Ruby opens up about pregnancy after infertility while battling OCD and intrusive thoughts, navigating severe nausea called hyperemesis gravidarum (HG), and what it felt like to hold hope and despair at the same time, and how becoming pregnant didn't magically erase the mental health struggles she was carrying. Because as many of us know: having babies doesn't fix everything — you still have to heal. She also talks about getting pregnant again, and having HG a second time. Now a mom of three kiddos, Ruby reflects on what she wishes she'd known, how she got support, and why talking honestly about maternal mental health might be the most important thing we can do for each other.Follow her on IG: @rubydu91 And TikTok: ruby.duEPISODE SPONSORS: THE WORK OF ART BOOK SERIESAli's Children's Book Series about IVF, IUI and Family Building Through Assisted Reproductive Technology https://www.infertileafgroup.com/booksThe latest book in the Work of ART series, “You Are a Work of ART," is for every kiddo born through ART -- and the people who love them.Order "Work of ART," "Beautiful Bird" and "You Are a Work of ART," now at https://www.infertileafgroup.com/booksFERTILITY RALLYIG: @fertilityrallywww.fertilityrally.comNo one should go through infertility alone. Join the Worst Club with the Best Members at fertilityrally.com. We offer 5 to 6 support groups per week, three private Facebook groups, tons of curated IRL and virtual events, and an entire community of more than 500 women available to support you, no matter where you are in your journey.Join today at link in bio on IG @fertilityrally or at www.fertilityrally.com/membershipPHERDALIG: @pherdal_sciencePherDal is the world's first and only FDA-cleared, sterile, at-home insemination kit designed to help people build their families in the comfort of home. Created by parents who've been there, PherDal is safe, simple, and affordable—putting more options in your hands as you grow your family. Explore at PherDal.com.Go to PherDal.com today and use code INFERTILEAF for $10 off.BERRY FERTILITYIG: @berry.fertilityThe Berry Fertility app is packed with support: dozens of injection tutorials, over 100 articles, 200 FAQs, and if you still have questions, the Berry team is literally a tap away through in-app chat.Berry has a free version, and you can try Premium free for seven days. After that, it's $12.99 a month or $99 for the year.InfertileAF listeners get 30% off an annual membership with the code INFERTILEAF when you sign up at berryfertility.com or in the Berry Fertility app.Our Sponsors:* BetterHelp makes it easy to get matched online with a qualified therapist. Sign up today and get 10% off at BetterHelp.com Support this podcast at — https://redcircle.com/infertile-af-infertility-and-modern-family-building-through-art/donationsAdvertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy

Governor Tim Walz and President Trump have a “productive conversation” as Tom Homan heads to Minnesota, the Minneapolis protests reveal an organized network, and the FDA moves to bring more medication out from behind the counter. Get the facts first with Morning Wire. - - - Ep. 2601 - - - Wake up with new Morning Wire merch: https://bit.ly/4lIubt3 - - - Today's Sponsor: DeleteMe - Get 20% off your DeleteMe plan when you go to https://joindeleteme.com/ WIRE and use promo code WIRE at checkout. - - - Privacy Policy: https://www.dailywire.com/privacy morning wire,morning wire podcast,the morning wire podcast,Georgia Howe,John Bickley,daily wire podcast,podcast,news podcast Learn more about your ad choices. Visit podcastchoices.com/adchoices

What if the key to healing your body, calming your mind, and extending your life has been inside you the whole time? In this episode, I sit down with one of the most important scientists alive today, Dr. Kevin Tracey, and I do not say that lightly. Kevin is a neurosurgeon, neuroscientist, and the pioneer behind a discovery that could fundamentally change how we treat disease, mental health, and inflammation. I have wanted him on this show for a long time, and after this conversation, you will understand why. This is one of those episodes where you grab a notebook, because it will completely shift how you think about your body, your brain, and your health. We break down the vagus nerve in plain English and why it may be the master regulator of inflammation, stress, trauma, and longevity. Kevin explains how chronic inflammation is linked to most of the diseases that shorten our lives and how the nervous system acts like the brakes that keep inflammation from spinning out of control. He walks us through the groundbreaking FDA approved therapy using vagus nerve stimulation that is already helping people with rheumatoid arthritis get out of wheelchairs, return to work, and reclaim their lives. And yes, he believes this is just the beginning. We also go deep into the connection between childhood trauma, chronic stress, anxiety, and physical disease. Kevin explains how unhealed stress can leave a biological imprint on the nervous system for decades and how that imprint can quietly drive inflammation throughout the body. We talk about depression, anxiety, heart rate variability, and why your body may be stuck in fight or flight without you even realizing it. This is not theory. This is real science, explained in a way that actually makes sense. Then we get practical. We talk about daily habits that cost nothing but can make a real difference. Breathing, prayer, meditation, cold exposure, exercise, sleep, and why doing hard things on purpose can build both mental resilience and physical health. Kevin is refreshingly honest about what science knows, what it does not know yet, and what questions we should be asking next. That humility is exactly why I trust his work. This conversation left me fired up, hopeful, and honestly in awe of what is coming next in medicine. If you care about your health, your performance, your longevity, or understanding how your mind and body truly work together, this is a must listen. And do yourself a favor and grab his book The Great Nerve. There is not a wasted page. Key Takeaways Why inflammation is at the root of most chronic disease and how the nervous system controls it How the vagus nerve acts as the brake pedal for stress, trauma, and inflammation The revolutionary FDA approved vagus nerve therapy already changing lives How childhood stress can biologically shape your health decades later Simple daily practices that may help calm your nervous system and improve wellbeing If you want to understand the future of health and how to take control of your body from the inside out, this episode will open your eyes. Share this one with someone you love. Max out. ⁠⁠

This week's episode is presented by Hollywood's premier foot feminization service, "From Hooves to Haute." With our patented treatment derived from centuries of Icelandic foot worship, our clinicians will transform your neglected feet from beige, flaky oatmeal buckets with fossilized Fritos for toenails into the epitome of luminous symmetry. We'll erase that eye-watering aroma of gangrene at low-tide and replace it with that of dried French lavender on a windowsill during Summer in Aix-en-Provence. Using precision tools, industrial-grade exfoliation, and aesthetic reshaping protocols, we systematically retire every yellowed talon and flaky canyon with calm, scientific efficiency. You'll see clinically smooth skin, balanced nail architecture, soft hydrated surfaces, and a clean visual profile that suggests health, elegance, and a guaranteed 4.99 on wikiFeet. Need a website? Head to https://Squarespace.com for a free trial, and when you're ready to launch, go to: https://www.squarespace.com/BALD to save 10% off your first purchase of a website or domain. Ro offers the first FDA-approved GLP-1 pill for weight loss at the lowest cost around! To see if you're eligible for the new GLP-1 pill on Ro, head to: https://Ro.co/BALD Right now, to get started with 50% off Green Chef + a FREE Graza Olive Oil Set in your 2nd and 3rd boxes, use code BALDGRAZA at: https://Greenchef.com/BALDGRAZA Need a new pair of glasses? Our listeners get 15% off plus free shipping when they buy two or more pairs of prescription glasses at: https://WarbyParker.com/BALD Follow Trixie: @TrixieMattel Follow Katya: @Katya_Zamo To watch the podcast on YouTube: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/TrixieKatyaYT⁠⁠⁠⁠ To check out our official YouTube Clips Channel: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/TrixieAndKatyaClipYT⁠⁠⁠⁠ Don't forget to follow the podcast for free wherever you're listening or by using this link: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://bit.ly/thebaldandthebeautifulpodcast⁠⁠⁠⁠ If you want to support the show, and get all the episodes ad-free go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://thebaldandthebeautiful.supercast.com⁠⁠⁠⁠ To check out future Live Podcast Shows, go to: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://trixieandkatya.com/#tour⁠⁠⁠⁠ To check out the Trixie Motel in Palm Springs, CA: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemotel.com⁠⁠⁠⁠ Listen and Watch Anywhere! ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠http://bit.ly/thebaldandthebeautifulpodcast⁠⁠⁠⁠ Follow Trixie: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.trixiemattel.com⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@trixie⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/trixiemattel⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/trixiemattel⁠⁠⁠⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/trixiemattel⁠⁠⁠⁠   Follow Katya: Official Website: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.welovekatya.com⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.tiktok.com/@katya_zamo⁠⁠⁠⁠ Facebook: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.facebook.com/welovekatya⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.instagram.com/katya_zamo⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter (X): ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://twitter.com/katya_zamo⁠⁠⁠⁠   #TrixieMattel #KatyaZamo #BaldBeautiful Learn more about your ad choices. Visit podcastchoices.com/adchoices